Description
ASP-3026 inhibits anaplastic lymphoma kinase (ALK) and shows anticancer chemotherapeutic activity. Treatment with ASP-3026 lowers tumor burden in lung and intrapleural tumor models.
Product Unit Size | Cost | Quantity | Stock |
---|
ASP-3026 inhibits anaplastic lymphoma kinase (ALK) and shows anticancer chemotherapeutic activity. Treatment with ASP-3026 lowers tumor burden in lung and intrapleural tumor models.
Cas No. | 1097917-15-1 |
---|---|
Purity | ≥98% |
Formula | C29H40N8O3S |
Formula Wt. | 580.74 |
Chemical Name | 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N- (2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine |
IUPAC Name | 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N- (2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine |
Synonym | ASP-3026, ASP 3026 |
Solubility | DMSO 14 mg/mL (24.1 mM) Water Insoluble Ethanol Insoluble |
Appearance | White Crystal Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
www.clinicaltrials.gov/show/NCT01284192
www.clinicaltrials.gov/show/NCT014001504